EMA public launch event on the guideline on good pharmacovigilance practices Module XVI on risk minimisation measures and its Addendum II, Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 September 2024, 10:00 (CEST) to 11 September 2024, 11:30 (CEST)

Human medicines European public assessment report (EPAR): Dimethyl fumarate Accord, dimethyl fumarate, Date of authorisation: 22/04/2024, Status: Authorised

Dates of 2025 Scientific Advice Working Party (SAWP) meetings and submission deadlines scientific advice, protocol assistance, qualification of biomarkers and EMA/EUnetHTA parallel consultation requests

Human medicines European public assessment report (EPAR): Syfovre, pegcetacoplan, Status: Opinion

EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna

Ninth Industry Standing Group (ISG) meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 28 June 2024, 09:00 (CEST) to 28 June 2024, 13:25 (CEST)

Presentation - International collaboration to facilitate medicines availability global assessment / inspection pathways

Presentation - Update on Network Portfolio activities

Presentation - Revised CTIS transparency rules and new version of the public portal

Presentation - Update on the development of the European Shortages Monitoring Platform (ESMP)